Gina Massa Mias
Oficial de Cumplimiento en ESBATech, a Novartis Co. GmbH .
Perfil
Ms. Gina M.
Mias is a Principal at Novartis AG and Head-Finance & Compliance Officer at ESBATech AG.
She received her undergraduate degree from the University of Massachusetts and an MBA from the University of Massachusetts.
Cargos activos de Gina Massa Mias
| Empresas | Cargo | Inicio |
|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Oficial de Cumplimiento | - |
Antiguos cargos conocidos de Gina Massa Mias.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Formación de Gina Massa Mias.
| University of Massachusetts | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Empresas privadas | 1 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Gina Massa Mias
